Processes and intermediates for the preparation of aspartic acetal caspase inhibitors

Details for Australian Patent Application No. 2012201242 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Jones, Andrew D.; Guerin, David J.; Tanoury, Gerald J.; Nyce, Philip L.; Trudeau, Martin; Chen, Minzhang; Snoonian, John R.

Agent Spruson & Ferguson

Pub. Number AU-A-2012201242

Parent 2005223767

Filing date 1 March 2012

Wipo publication date 22 March 2012

International Classifications

C07B 43/04 (2006.01) Formation or introduction of functional groups containing nitrogen

C07B 57/00 (2006.01) Separation of optically-active compounds

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

22 March 2012 Application Open to Public Inspection

  Published as AU-A-2012201242

22 March 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201243-Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium spp

2012201241-A grid tied inverter, system and method